Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Consequences of Anti-GFAP Antibodies on the Peripheral Nervous System

NCT05742087 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT05742087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05742087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Consequences of Anti-GFAP Antibodies on the Peripheral Nervous System
Lead sponsor
Hospices Civils de Lyon
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2022
Completion date
May 1, 2023
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurological diseases associated to anti gfap antibodies, neurological diseases or conditions